Has Amador Dizon, MD received payments from drug or device companies?

Yes. Drug and device makers reported $380 in general payments to Amador Dizon, MD across 24 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Amador Dizon, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Amador Dizon, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Amador Dizon, MD

Psychiatry · Fargo, NDNPI 1821175241

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 24 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 10 manufacturers, the largest accounting for just 18.5% — the pattern of someone who eats at a lot of different presentations.

$380in general payments, 2019–2025

Across 24 payments — averaging $15.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Lundbeck LLC$70
Alkermes, Inc.$60
AbbVie$59
Neurocrine Biosciences, Inc.$42
E.r. Squibb & Sons, L.L.C.$38
Axsome Therapeutics, Inc.$34
plus $76 from 4 others

What the payments were for

Food & beverage$380100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Lundbeck LLC	4	$70
Alkermes, Inc.	4	$60
AbbVie	3	$59
Neurocrine Biosciences, Inc.	3	$42
E.r. Squibb & Sons, L.L.C.	2	$38
Axsome Therapeutics, Inc.	2	$34
Teva Pharmaceuticals USA, Inc.	2	$27
Takeda Pharmaceuticals U.S.A., Inc.	2	$20
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	1	$14
Ironshore Pharmaceuticals Inc.	1	$14

How this compares

$380 in reported general payments places this provider in the 70th percentile of 63 psychiatry providers in North Dakota.

See all psychiatry providers in North Dakota →

Medicare billing

Part B allowed, 2024

$13,064

Medicare patients

Services billed

115

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
RexultiBrexpiprazole	65	$91,932
VraylarCariprazine Hcl	40	$55,918
Invega SustennaPaliperidone Palmitate	13	$43,308
LybalviOlanzapine/Samidorphan Malate	13	$23,774
VyvanseLisdexamfetamine Dimesylate	34	$12,465
TrintellixVortioxetine Hydrobromide	23	$10,950
SeroquelQuetiapine Fumarate	11	$8,590
Lisdexamfetamine Dimesylate	30	$6,078
Divalproex Sodium ErDivalproex Sodium	89	$4,943
Clozapine	76	$3,175
Citalopram HbrCitalopram Hydrobromide	82	$3,166
Ziprasidone Hcl	123	$3,139
Olanzapine	75	$3,023
Paliperidone ErPaliperidone	27	$2,716
Aripiprazole	82	$2,236

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
AbbVieVraylar	$59	$55,91840 claims
Alkermes, Inc.Lybalvi	$60	$23,77413 claims
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse, Trintellix	$20	$23,41457 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 63 psychiatry providers in North Dakota.

Other psychiatry in Fargo

James MitchellFargo$4K
Albert AllickFargo$3K
Robert StatonFargo$648
Leah ThompsonFargo$550
Carol WhitmanFargo$344
Jennifer MyersFargo$270
Ali PervaizFargo$232
Kyle CleasbyFargo$150
Jennifer BradyFargo$137
Lisa SchockFargo$118

See the full list for North Dakota →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →